Genetic susceptibility to Gilbert's syndrome in a Valencian population; efficacy of the fasting test-Reference-Cited by-同舟云学术

Genetic susceptibility to Gilbert's syndrome in a Valencian population; efficacy of the fasting test

Published:2017-01 Issue:1 Volume:217 Page:1-6
ISSN:2254-8874
Container-title:Revista Clínica Española (English Edition)
language:en
Short-container-title:Revista Clínica Española (English Edition)

Author:

Torres A.K.,Escartín N.,Monzó C.,Guzmán C.,Ferrer I.,González-Muñoz C.,Peña P.,Monzó V.,Marcaida G.,Rodríguez-López R.

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. Síndrome de Gilbert;Vicente Diez;Rev Esp Geriatr Gerontol,2002

2. Hereditary hyperbilirubinemias;Radlović;Srp Arh Celok Lek,2014

3. Síndrome de Gilbert ¿qué es y cómo diagnosticarlo?;Campuzano Maya;Med Lab,2006

4. Síndrome de Gilbert: estudio de 12 observaciones y revisión de la bibliografía médica;Delgado Peña;Acta Pediatr Esp,2007

5. Presentación inusual de la enfermedad de Gilbert con altos niveles de bilirrubina no conjugada. Presentación de dos casos;Flores-Villalba;Rev Esp Enferm Dig,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Safety of Direct-Acting Antiviral Agentsin Patients with Chronic HCV-Infection and with UGT1A1*28 Polymorphism;Клиническая инфектология и паразитология;2020-10-15

2. The Evaluation of the Efficacy and Safety of Patients with Chronic Hepatitis C and Cirrhosis with Polymorphism UGT1A1*28 Treatment with Direct Antiviral Drugs and Ribavirin;Рецепт;2020-07-21

3. The efficacy and safety of direct-acting antiviral agents in patients with chronic HCV infection and UGT1A1*28 polymorphism;Clinical Microbiology and Antimicrobial Chemotherapy;2020

4. UGT1A1 (TA)n promoter genotype: Diagnostic and population pharmacogenetic marker in Serbia;Balkan Journal of Medical Genetics;2018-06-01